Epithalon
Reported Onset
4–8 weeks
Primary Use
Telomere lengthening, cellular longevity, and improved sleep quality.
Dose
5mg - 10mg
Frequency
Daily for 10-20 day cycles, 1-2x per year
MOTS-C
Reported Onset
2–4 weeks
Primary Use
Metabolic regulation, insulin sensitivity improvement, and exercise mimetic effects.
Dose
5mg - 10mg
Frequency
3-5x weekly
Community Verdict
Telomere lengthening vs mitochondrial exercise mimetic. The community generally selects between Epithalon and MOTS-C based on their specific goals and experience. Both compounds are available through physician-supervised protocols at Alukard, where a physician can help determine which is most appropriate for your situation.
Get a Physician-Supervised Protocol for Epithalon or MOTS-C at Alukard
Community experiences are a starting point — but a physician-supervised protocol from Alukard gives you pharmaceutical-grade compounds, proper dosing, lab monitoring, and the safety of medical oversight.
MD
Supervised
GMP
Certified
Labs
Monitoring
COA
Verified